Digestive Health

EVNol Tocotrienol may beat omeprazole in controlling gastric issues

12 Dec 2017 --- ExcelVite’s EVNol tocotrienol was found to be more effective in treating gastric growth factors in stress-exposed rats than omeprazole, a common medication used in the treatment of gastroesophageal reflux disease and peptic ulcer disease. This is according to a recently published study in the World Journal of Gastroenterology that suggests more investigation is warranted.
 

Stem cells in intestinal lining may shed light on behavior of cancer cells

29 Nov 2017 --- The lining of the intestines – the epithelium – has been found to do more than just absorb nutrients. It grows, shrinks, and adjusts the makeup of its cells in response to whatever has just been eaten, and understanding that process could give scientists new insights into the behavior of cancer cells, according to findings published in the Journal of Cellular Physiology.

Studies with FrieslandCampina’s Vivinal GOS show increased uptake of iron and improved gut microbiome

27 Nov 2017 --- Two recent studies have led to new insights into supplements containing FrieslandCampina’s Vivinal GOS. The first study showed an increase in iron absorption by 62 percent upon supplementation with Vivinal GOS in iron-deficient Kenyan infants. Additionally, the second study revealed that adding Vivinal GOS mitigated the adverse effects of iron supplementation on gut microbiota and infections.

Gut bacteria sensitive to salt, linked to MS and hypertension: study

20 Nov 2017 --- Common salt reduces the number of certain lactic acid bacteria in the gut of mice and humans. This is according to a study published in the journal Nature by Berlin's Max Delbrück Center and Charité, which further notes an impact on immune cells that are partly responsible for autoimmune diseases like multiple sclerosis (MS) and hypertension. Probiotics were also found to ameliorate the symptoms of disease in mice.

High level of dietary fiber in MGP’s Fibersym RW resistant wheat starch confirmed by study

15 Nov 2017 --- Food ingredients supplier MGP’s Fibersym RW resistant wheat starch contains an “extraordinarily” high level of dietary fiber, according to results of a human dietary study recently conducted at Monash University in Melbourne, Australia. MGP notes that the study was conducted to determine what percentage of the ingredient is digestible when consumed in a meal.

Study shows positive impact of DuPont Danisco Litesse Polydextrose carbohydrate on microbiome

09 Nov 2017 --- The findings of a DuPont Nutrition & Health research study show that DuPont Danisco Litesse Ultra polydextrose alters the gut microbiome and reduces fasting triglyceride and total cholesterol plasma levels in mice being fed a Western diet. The study is a continuation of the microbiome research work DuPont Nutrition & Health is doing in conjunction with the University of Oulu Medical School in Finland.

Microbiome Therapeutics prepares to launch first microbiome modulator after completing Series B financing

08 Nov 2017 --- MicroBiome Therapeutics, LLC (MBT), a company that applies the science of the gastrointestinal (GI) microbiome to promote health and wellness, has announced the completion of a Series B financing that raised approximately US$1 million. MBT intends to use the proceeds to launch its clinically-tested microbiome modulator product in 2018.

Wholesome: Large-scale study underpins the health benefits of whole grains

03 Nov 2017 --- Exchanging refined grain products – such as white bread and pasta – with whole grain varieties causes overweight adults to eat less, lose weight, leading to a decrease in the amount of inflammation in their bodies. These are some of the findings of Danish study headed by the National Food Institute, Technical University of Denmark. The study supports the scientific basis for the dietary recommendations of many countries to choose whole grains.

Autophagy-activating foods like pomegranates help prevent gut diseases

03 Nov 2017 --- Colon cancer, Crohn’s and other diseases of the gut could be better treated – or even prevented – thanks to a new link between inflammation and a common cellular process that has been established by the UK’s University of Warwick. Led by Dr. Ioannis Nezis at Warwick’s School of Life Sciences, new research demonstrates that autophagy – an essential process whereby cells break down and recycle harmful or damaged elements within themselves to keep our bodies healthy – causes tissue inflammation when dysfunctional, which in turn leaves us susceptible to harmful diseases, particularly in the gut.

Bifodan expands global presence with new office in Milan

03 Nov 2017 --- Danish probiotics company Bifodan has established a regional sales office in Milan, Italy. The move increases its global presence to four offices on the European continent and three offices in the US, from which it intends to serve the global market.

Digestive health: Naturex and Olene partner on ginger extract powder

30 Oct 2017 --- Naturex and India-based Olene have partnered through Ingenium, Naturex’s Open Innovation Program, to bring Gingest to the global market. Gingest is a new, highly standardized ginger extract powder for natural digestive health applications.

Evidence of inhibiting effect of curcumin complex and aspirin combination in colorectal cancer: study

30 Oct 2017 --- Researchers have found evidence of the inhibitory effect in colon tumorigenesis of a low dose combination of aspirin and Sabinsa’s Curcumin C3 Complex. The findings have been published in the journal Biochemical Pharmacology.

Indena’s curcumin supplement records new positive results in gastrointestinal health

27 Oct 2017 --- A new double-blind placebo-controlled human study has revealed that a short-term dietary curcumin-based supplementation with Indena’s Meriva curcumin may be helpful in the maintenance of the gastrointestinal barrier integrity and physiological strain responses during exertional heat stress. The study was conducted independently by a team of American researchers at High Point University in North Carolina, US.

Dried cranberries have potential for boosting gut health

25 Oct 2017 --- Researchers from the University of Wisconsin-Madison have evaluated whether one simple addition to the diet – one handful a day of sweetened dried cranberries – could positively influence the gut microbiome. After just two weeks and with only ten subjects, the differences were statistically insignificant but according to the researchers, were moving in the right direction, pointing to a role for cranberries in improving gut health.

The Gluten Free Bar’s Power Breakfast range puts convenience spin on traditional oatmeal

25 Oct 2017 --- Snack brand The Gluten Free Bar (GFB) is aiming to push the envelope of inventive snack food creation with the introduction of its new oatmeal line, GFB Power Breakfast, available in five varieties: Coconut Cashew; Fruits, Nuts, and Seeds; PB+J; Apple Cinnamon; and Maple Raisin. Each Power Breakfast variety features high-protein oatmeal with no added sugar and a healthy mix of add-ins including sun-ripened fruit, nuts and seeds. 

Research predicts rise in IBD in developing world

24 Oct 2017 --- For the last century, inflammatory bowel disease (IBD) has been a challenge for patients and the medical community in the Western world. Now, research published in The Lancet by Dr. Gilaad Kaplan shows that countries outside the Western world may now be facing the same pattern of increasing IBD rates.

“Ridiculously healthy” elderly have same gut microbiome as healthy 30-year-olds, according to study

12 Oct 2017 --- A potential strong link between healthy aging and a healthy gut has been shown by one of the largest microbiota studies conducted in humans. The China-Canada Institute researchers studied the gut bacteria in a cohort of more than 1,000 Chinese people in a variety of age ranges from 3 to over 100 years old. The subjects were self-selected to be extremely healthy with no known health issues and no family history of disease. The results showed a direct correlation between health and the microbes in the intestine.

Awareness of celiac disease low in Canada despite gluten-free NPD boom: study

09 Oct 2017 --- Research on a large sample of Canadians suggests that most people with celiac disease are unaware that they have it. Researchers studied the blood work of almost 3,000 Canadians and found that one in 114 (or almost one percent) had elevated antibodies that indicate they suffered from celiac disease, which causes gastric distress and other symptoms. However, almost 90 percent were unaware they had the disease. 

Synbiotics: The best of both worlds (Part 2) – Innovations and NPD opportunities

06 Oct 2017 --- Synbiotics – dietary supplements or functional food ingredients that contain both prebiotics and probiotics – are seeing a lot of innovations and new products take hold within their specialized space. Today, in the second part of a special report, NutritionInsight looks at these changes with some insights from companies that are producing synbiotics.

LNC Therapeutics raises €6.5m to reinforce its R&D in the microbiota field

29 Sep 2017 --- LNC Therapeutics, a company specialized in the research and development of gut microbiota directed drugs for the treatment of obesity and associated cardiometabolic diseases, has raised a €6.5 million (US$7.67 million) Series C funding round. This new round, co-led by Seventure Partners, brings together a consortium of investors and a family office. Additionally, the company has appointed a new chief scientific officer, Dr. Sandrine Claus, to lead the gut microbiota project.